![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1279883
¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : À¯Çüº°(½ÉÀå º¸Ã¶Àåºñ, Ç÷°ü º¸Ã¶Àåºñ), ÃÖÁ¾ »ç¿ëÀÚº°(º´¿ø, Áø·á¼Ò, ±âŸ), Áö¿ªº° ºÐ¼®(2023-2030³â)Global Cardiovascular Prosthetic Devices Market Size study & Forecast, by Type( Cardiac prosthetic devices, Vascular Prosthetic Devices) by End User (Hospitals, Clinics, Others) and Regional Analysis, 2023-2030 |
¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀåÀº 2022³â ¾à 269¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 8.6% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º´Â ½ÉÇ÷°ü ½Ã½ºÅÛÀÇ ±â´ÉÀ» ´ëüÇϰųª Áö¿øÇϱâ À§ÇØ ¼³°èµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. À̵éÀº ÁÖ·Î ´Ù¾çÇÑ ½ÉÀå »óÅÂ¿Í Áúº´À» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀåÀº ½ÉÇ÷°ü Áúȯ ¹× ¼ö¼úÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
¿¹¸¦ µé¾î Centers for Disease Control and Prevention(CDC)ÀÌ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é °ü»óµ¿¸Æ¼º ½ÉÀ庴Àº °¡Àå ÈçÇÑ Áúº´À¸·Î 2020³â ¹Ì±¹¿¡¼ 38¸¸ 2820¸íÀÇ ¸ñ¼ûÀ» ¾Ñ¾Æ°©´Ï´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ 65¼¼ ¹Ì¸¸ ¼ºÀÎÀÇ °ü»óµ¿¸ÆÁúȯ(CAD)À¸·Î ÀÎÇÑ »ç¸ÁÀº 2020³â ¾à 10¸í Áß 2¸í²Ã·Î ¹ß»ýÇÑ´Ù°í ÇÕ´Ï´Ù. ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽ºÀÇ »ç¿ëÀº ½ÉÇ÷°ü ¼ö¼ú Áõ°¡·Î ÀÎÇØ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ±¹¸³ ÀÇÇÐ µµ¼°üÀº 2022³â 9¿ù ¼¼°è¿¡¼ ¿¬°£ 20¸¸ °Ç ÀÌ»óÀÇ ½ÉÀå ÆÇ¸· ±³Ã¼ ¼ö¼úÀÌ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, 2050³â¿¡´Â ¿¬°£ 8,50,000 °ÇÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÈ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ °ü»óµ¿¸Æ¿ìȸ¼ú(CABG)Àº ¿¬°£ 40¸¸ °Ç¿¡ À°¹ÚÇϸç ÁÖ¿ä ¼ö¼ú Áß °¡Àå ÈçÇÑ ¼ö¼ú·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ½ÉÀå Áúȯ Áõ°¡¿Í ¼ö¼ú °Ç¼ö Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼ú ¹ßÀü Áõ°¡¿Í À¯¸®ÇÑ ÀÇ·áºñ »óȯ Á¤Ã¥Àº ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽ºÀÇ °íºñ¿ëÀ¸·Î ÀÎÇØ 2023-2030³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.
¼¼°è ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÇ´Â ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ½ÉÀå Áúȯ Áõ°¡, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç, ÀÌ Áö¿ªÀÇ ±â¼ú ¹ßÀü Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ ¹× Áúº´ Áõ°¡, Á¦Ç° °³¹ßÀ» À§ÇÑ °øµ¿ ¿¬±¸ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Áö¿ªÀû È®Àå, Á¤ºÎ ±â°ü ¹× ºñ¿µ¸® ´Üü ½ÃÀå ÁøÀÔ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¼ö³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ȯ°æ°ú °æÀï ±¸µµ¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.
Global Cardiovascular Prosthetic Devices Market is valued approximately USD 26.94 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2023-2030. Cardiovascular prosthetic devices are medical devices designed to replace or support the function of the cardiovascular system. They are primarily used in the treatment of various heart conditions and diseases. The Cardiovascular Prosthetic Devices market is expanding because of factors such as an increase in the prevalence of cardiovascular disorders and surgeries and growing geriatric population.
For instance, according to a data released by the Centres for Disease Control and Prevention (CDC), coronary heart disease is the most prevalent form of the disease and claimed 382,820 lives in the United States in 2020. Additionally, about 2 in 10 deaths from coronary artery disease (CAD) in adults under 65 years of age will occur in 2020. The use of cardiovascular prosthetic devices is expected to be driven by the rise in cardiovascular procedures, which will also fuel market expansion. For instance, the National Library of Medicine announced in September 2022 that more than 200,000 heart valve replacement procedures are carried out annually worldwide, with an increase to 8,50,000 per year expected by 2050. Additionally, nearly 400,000 coronary artery bypass grafting (CABG) surgeries are performed annually, making it the most common major surgical procedure. Thus, rising prevelance of cardiac disorders and the increase in number of surgeries performed is fostering the market growth. In addition, rising technological advancements and favorable Health Reimbursement Policies are creating a lucrative opportunity to the market. However, the high cost of Cardiovascular Prosthetic Devices stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Cardiovascular Prosthetic Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising prevelance cardiac disorders, presence of key market players, and rising technological advancements in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and diseases prevelance, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.